Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

8.64
Delayed Data
As of Apr 29
 +0.04 / +0.47%
Today’s Change
6.60
Today|||52-Week Range
10.83
-11.84%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close8.60
Today’s open8.17
Day’s range8.17 - 8.65
Volume13,945
Average volume (3 months)32,594
Market cap$195.4M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-27.08%
Earnings growth (next 5 years)-6.32%
Revenue growth (last year)+6.98%
P/E ratio--
Price/Sales4.53
Price/Book1.43

Competitors

 Today’s
change
Today’s
% change
SZYMSolazyme Inc+0.03+1.30%
AKTXAkari Therapeutics P...+0.20+1.18%
PFNXPfenex Inc-0.37-4.34%
OSIROsiris Therapeutics ...-0.26-4.43%
Data as of 4:02pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)$0.05
Annual revenue (last year)$50.4M
Annual profit (last year)$6.7M
Net profit margin13.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Vice President-
Operations
Yariv Gratz
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts

Partner Offers

Search for Jobs